Call for Postdoctoral Fellowship Applications
Harvard Medical School/Brigham and Women’s Hospital Program On Regulation, Therapeutics, And Law (PORTAL)
Deadline: February 16, 2018
The Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital Department of Medicine and Harvard Medical School invites its 2018 round of applications for postdoctoral fellows in pharmaceutical law and health services research. Current fellows have studied FDA regulation, patents, drug access and costs, and competition in the therapeutic marketplace. Other areas of focus include intellectual property, ethics, and comparative effectiveness, as well as the development, approval, and evidence-based use of drugs, devices, vaccines, procedures, and diagnostics.
Applications are invited from researchers with doctoral degrees (J.D., M.D., Ph.D., Pharm.D., or equivalent) or who will complete such training by July 2018. Fellows will have an appointment at Harvard Medical School, receive close mentorship from faculty members in the Division, and engage in one or more projects intended to start their careers in law and public health research. Fellowship length will vary depending on the candidate (Minimum: 1 year).
The deadline is February 16, 2018. To apply, please send to email@example.com: (1) a CV, (2) a writing sample, and (3) a cover letter describing your past work, ideas for the kind of research you’d like to do in the fellowship, and career goals. The Division of Pharmacoepidemiology and Pharmacoeconomics is a close-knit 70-member interdisciplinary research center. Our work focuses on the evaluation, regulation, outcomes, and cost-effectiveness of prescription drugs and medical devices, as well as the development and evaluation of policies to improve use of therapeutics.
E-mail Ameet Sarpatwari, J.D., Ph.D. at firstname.lastname@example.org with any questions.
Brigham and Women’s Hospital and Harvard Medical School are Equal Opportunity/Affirmative Action Employers; women and members of underrepresented minority groups are strongly encouraged to apply.fellowship opportunity pharmaceuticals